This basic science study characterizes the lariat RNA structure as an intermediate in mRNA splicing.
Answers are grounded in this paper and cite their sources.
No immediate clinical impact; leaves open branchpoint targeting for splicing modulation research.
The splicing of messenger RNA precursors in vitro proceeds through an intermediate that has the 5' end of the intervening sequence joined to a site near the 3' splice site. This lariat structure, which has been characterized for an adenovirus 2 major late transcript, has a branch point, with 2'-5' and 3'-5' phosphodiester bonds emanating from a single adenosine residue. The excised intervening sequence retains the branch site and terminates in a guanosine residue with a 3' hydroxyl group. The phosphate group at the splice junction between the two exons originates from the 3' splice site at the precursor.
No takes yet. Share an insight, caveat, or question.
Padgett et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: